NCI-CPTAC DREAM Proteogenomics
Learn More Cancer is driven by aberrations in the genome [1,2], and these alterations manifest themselves largely in the changes in the
Learn More Cancer is driven by aberrations in the genome [1,2], and these alterations manifest themselves largely in the changes in the
Learn More The Digital Mammography DREAM Challenge will attempt to improve the predictive accuracy of digital mammography for the early detection of
Learn More Multiple myeloma (MM) is a cancer of the plasma cells in the bone marrow, and its clinical course depends on
Learn More The ICGC-TCGA DREAM Somatic Mutation Calling - RNA Challenge (SMC-RNA) is an international effort to improve standard methods for identifying
Learn More Physiological and disease processes are typically not driven by a single gene, but multiple genes that interact within molecular modules
Learn More Respiratory viruses are highly infectious and cause acute illness in millions of people every year. However, there is wide variation
Learn More What is tumour heterogeneity? Tumors are composed of many different cell types, ranging from the normal tissue micro-environment, infiltrating immune
Learn More The ICGC-TCGA DREAM Somatic Mutation Calling Meta-pipeline Challenge (SMC-DNA Meta) (herein, The Challenge) is an international effort to improve standard
Learn More Targeted therapies and personalized treatments are the most promising assets to treat cancer. However, in many patients, a tumor’s innate
Learn More Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease that typically leads to death within 3-5 years but for